Novartis AG (ADR) - NVS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Novartis AG (ADR) - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
NVS	New York	2834	http://www.novartis.com/	71.90 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Novartis AG (ADR) Novo Nordisk Patent Found Invalid - Jun 19th, 2013 3:40 pm David Pyott Isn't Just A Pretty Face At Allergan - Jun 19th, 2013 11:49 am This Blockbuster Biologic May Face a Steep Cliff - Jun 19th, 2013 8:46 am Europe Fines Drug Companies for Delaying Generics - Jun 19th, 2013 5:49 am Positive Data on Novartis' Jakavi - Jun 18th, 2013 2:55 pm Positive Data on Incyte's Jakafi - Jun 18th, 2013 2:00 pm Ariad's Iclusig in GIST Phase II Study - Jun 18th, 2013 1:30 pm Big Pharma's Intellectual Property Blues - Jun 18th, 2013 5:46 am Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate - Jun 17th, 2013 3:16 pm Good News for InterMune - Jun 17th, 2013 1:30 pm How big companies can beat the patent chaos of India - Jun 17th, 2013 12:08 pm J&J: Adding Another Pearl to its Acquisition Necklace - Jun 17th, 2013 9:13 am [video] Supreme Court Rules on 'Pay for Delay' - Jun 17th, 2013 8:19 am A Big Pharma Company With a Juicy Dividend Yield and Low Valuation - Jun 16th, 2013 6:10 am 3 Humongous Health-Care Stocks This Week - Jun 15th, 2013 10:32 am Is Johnson & Johnson A Buy At These Prices? - Jun 15th, 2013 8:10 am Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug - Jun 14th, 2013 3:51 pm Big Pharma's Biggest Opportunity - Jun 14th, 2013 2:29 pm Encouraging Data on Novartis' Gilenya - Jun 14th, 2013 2:25 pm A Must Have Pharma Stock - Jun 14th, 2013 10:14 am View All Current Headlines >>